European evidence-based guidelines on pancreatic cystic neoplasms

European Study Group on Cystic Tumours of the … - Gut, 2018 - gut.bmj.com
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …

[HTML][HTML] Updates in diagnosis and management of pancreatic cysts

LS Lee - World Journal of Gastroenterology, 2021 - ncbi.nlm.nih.gov
Incidental pancreatic cysts are commonly encountered with some cysts having malignant
potential. The most common pancreatic cystic neoplasms include serous cystadenoma …

Management of intraductal papillary mucinous neoplasms: controversies in guidelines and future perspectives

IJM Levink, MJ Bruno, DL Cahen - Current treatment options in …, 2018 - Springer
Purpose of review Management of intraductal papillary mucinous neoplasm (IPMN) is
currently based on consensus, in the absence of evidence-based guidelines. In recent …

Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm

T Hackert, S Fritz, M Klauss, F Bergmann… - Annals of …, 2015 - journals.lww.com
Objective: The 2012 international consensus guidelines for the management of intraductal
papillary mucinous neoplasms (IPMN) recommend surgical treatment in main-duct IPMN …

IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection

G Marchegiani, M Mino-Kenudson, K Sahora… - Annals of …, 2015 - journals.lww.com
Objectives: To describe the characteristics of intraductal papillary mucinous neoplasms
(IPMNs) with predominant involvement of the main pancreatic duct (MPD), analyzing …

Static and dynamic 68Ga-FAPI PET/CT for the detection of malignant transformation of intraductal papillary mucinous neoplasia of the pancreas

M Lang, AM Spektor, T Hielscher… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Pancreatic ductal adenocarcinoma (PDAC) may arise from intraductal papillary mucinous
neoplasms (IPMN) with malignant transformation, but a significant portion of IPMN remains …

“High-risk stigmata” of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the …

T Aso, T Ohtsuka, T Matsunaga, H Kimura… - Pancreas, 2014 - journals.lww.com
Objectives The 2012 international consensus guidelines for the management of intraductal
papillary mucinous neoplasm (IPMN) of the pancreas stratified patients into 2 clinical …

Molecular analysis of cyst fluids improves the diagnostic accuracy of pre-operative assessment of pancreatic cystic lesions

L Haeberle, M Schramm, W Goering, L Frohn… - Scientific reports, 2021 - nature.com
Pancreatic cystic lesions (PCL) are increasingly diagnosed. Endoscopic ultrasound fine-
needle aspiration (EUS-FNA) cytology is often used for diagnostic confirmation but can be …

[HTML][HTML] Clinical approach to incidental pancreatic cysts

AL Chiang, LS Lee - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
The approach to incidentally noted pancreatic cysts is constantly evolving. While surgical
resection is indicated for malignant or higher risk cysts, correctly identifying these highest …

Importance of main pancreatic duct dilatation in IPMN undergoing surveillance

G Marchegiani, S Andrianello, G Morbin… - Journal of British …, 2018 - academic.oup.com
Background The association between risk of pancreatic cancer and a dilated main
pancreatic duct (MPD) in intraductal papillary mucinous neoplasm (IPMN) is debated. The …